Bronchodilator efficacy of 18 µg once-daily tiotropium inhalation via Discair® versus HandiHaler® in adults with chronic obstructive pulmonary disease: randomized, active-controlled, parallel-group, open-label, Phase IV trial

Bronchodilator efficacy of 18 µg once-daily tiotropium inhalation via Discair® versus HandiHaler® in adults with chronic obstructive pulmonary disease: randomized, active-controlled, parallel-group, open-label, Phase IV trial

Pinar Yildiz, Mesut Bayraktaroglu, Didem Gorgun, Funda Secik Clinics of Chest Diseases, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey Purpose: To compare the bronchodilator efficacy of 18 µg once-daily tiotropium inhalation administered via...

Full description

Bibliographic Details
Main Authors: Yildiz P, Bayraktaroglu M, Gorgun D, Secik F
Format: Article
Language:English
Published: Dove Medical Press 2016-11-01
Series:International Journal of COPD
Subjects:
Non-inferiority
tiotropium
Discair
HandiHaler
bronchodilator efficacy
spirometry
Online Access:https://www.dovepress.com/bronchodilator-efficacy-of-18-microg-once-daily-tiotropium-inhalation--peer-reviewed-article-COPD

Internet

https://www.dovepress.com/bronchodilator-efficacy-of-18-microg-once-daily-tiotropium-inhalation--peer-reviewed-article-COPD

Similar Items